Former Secretary of State Mike Pompeo reacts to an explosive report on President Biden’s closed-door acuity as he fights for legitimacy on the world stage.

America’s unique free-market system has enabled the production of health care services and products for its citizens that are second-to-none, but misguided and foolish thinking at the government level now threatens to make drug prices unaffordable for families and senior citizens.

By targeting pharmacy benefit managers (PBM’s), the Federal Trade Commission will advance the Biden administration’s war on American business, expand government power, and raise drug costs for all Americans. Rather than go along with the FTC’s policies that will hurt patients and families, Congress should step in and put a stop to it.

Pharmacy benefit managers have long played a crucial role in keeping drug prices down. Indeed, our free-market health care system only works for consumers, patients and families if the various players are able to negotiate and compete, which is what ultimately allows patients access to lower prices.

Consumer Financial Protection Bureau Director Rohit Chopra and Federal Trade Commission Chair Lina Khan listen as President Biden speaks about the economy in the South Auditorium of the White House campus on Oct. 26, 2022. (Saul Loeb/AFP via Getty Images)

PBMs do just that: By negotiating with drug manufacturers, they secure lower drug prices for insurance companies so that patients and families win. As someone who........

© Fox News